Cargando…

Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype

Quantification of cell-free DNA (cfDNA) in circulating blood derived from a transplanted organ is a powerful approach to monitoring post-transplant injury. Genome transplant dynamics (GTD) quantifies donor-derived cfDNA (dd-cfDNA) by taking advantage of single-nucleotide polymorphisms (SNPs) distrib...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharon, Eilon, Shi, Hao, Kharbanda, Sandhya, Koh, Winston, Martin, Lance R., Khush, Kiran K., Valantine, Hannah, Pritchard, Jonathan K., De Vlaminck, Iwijn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542400/
https://www.ncbi.nlm.nih.gov/pubmed/28771616
http://dx.doi.org/10.1371/journal.pcbi.1005629
_version_ 1783254985077686272
author Sharon, Eilon
Shi, Hao
Kharbanda, Sandhya
Koh, Winston
Martin, Lance R.
Khush, Kiran K.
Valantine, Hannah
Pritchard, Jonathan K.
De Vlaminck, Iwijn
author_facet Sharon, Eilon
Shi, Hao
Kharbanda, Sandhya
Koh, Winston
Martin, Lance R.
Khush, Kiran K.
Valantine, Hannah
Pritchard, Jonathan K.
De Vlaminck, Iwijn
author_sort Sharon, Eilon
collection PubMed
description Quantification of cell-free DNA (cfDNA) in circulating blood derived from a transplanted organ is a powerful approach to monitoring post-transplant injury. Genome transplant dynamics (GTD) quantifies donor-derived cfDNA (dd-cfDNA) by taking advantage of single-nucleotide polymorphisms (SNPs) distributed across the genome to discriminate donor and recipient DNA molecules. In its current implementation, GTD requires genotyping of both the transplant recipient and donor. However, in practice, donor genotype information is often unavailable. Here, we address this issue by developing an algorithm that estimates dd-cfDNA levels in the absence of a donor genotype. Our algorithm predicts heart and lung allograft rejection with an accuracy that is similar to conventional GTD. We furthermore refined the algorithm to handle closely related recipients and donors, a scenario that is common in bone marrow and kidney transplantation. We show that it is possible to estimate dd-cfDNA in bone marrow transplant patients that are unrelated or that are siblings of the donors, using a hidden Markov model (HMM) of identity-by-descent (IBD) states along the genome. Last, we demonstrate that comparing dd-cfDNA to the proportion of donor DNA in white blood cells can differentiate between relapse and the onset of graft-versus-host disease (GVHD). These methods alleviate some of the barriers to the implementation of GTD, which will further widen its clinical application.
format Online
Article
Text
id pubmed-5542400
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-55424002017-08-12 Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype Sharon, Eilon Shi, Hao Kharbanda, Sandhya Koh, Winston Martin, Lance R. Khush, Kiran K. Valantine, Hannah Pritchard, Jonathan K. De Vlaminck, Iwijn PLoS Comput Biol Research Article Quantification of cell-free DNA (cfDNA) in circulating blood derived from a transplanted organ is a powerful approach to monitoring post-transplant injury. Genome transplant dynamics (GTD) quantifies donor-derived cfDNA (dd-cfDNA) by taking advantage of single-nucleotide polymorphisms (SNPs) distributed across the genome to discriminate donor and recipient DNA molecules. In its current implementation, GTD requires genotyping of both the transplant recipient and donor. However, in practice, donor genotype information is often unavailable. Here, we address this issue by developing an algorithm that estimates dd-cfDNA levels in the absence of a donor genotype. Our algorithm predicts heart and lung allograft rejection with an accuracy that is similar to conventional GTD. We furthermore refined the algorithm to handle closely related recipients and donors, a scenario that is common in bone marrow and kidney transplantation. We show that it is possible to estimate dd-cfDNA in bone marrow transplant patients that are unrelated or that are siblings of the donors, using a hidden Markov model (HMM) of identity-by-descent (IBD) states along the genome. Last, we demonstrate that comparing dd-cfDNA to the proportion of donor DNA in white blood cells can differentiate between relapse and the onset of graft-versus-host disease (GVHD). These methods alleviate some of the barriers to the implementation of GTD, which will further widen its clinical application. Public Library of Science 2017-08-03 /pmc/articles/PMC5542400/ /pubmed/28771616 http://dx.doi.org/10.1371/journal.pcbi.1005629 Text en https://creativecommons.org/publicdomain/zero/1.0/ This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 (https://creativecommons.org/publicdomain/zero/1.0/) public domain dedication.
spellingShingle Research Article
Sharon, Eilon
Shi, Hao
Kharbanda, Sandhya
Koh, Winston
Martin, Lance R.
Khush, Kiran K.
Valantine, Hannah
Pritchard, Jonathan K.
De Vlaminck, Iwijn
Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype
title Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype
title_full Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype
title_fullStr Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype
title_full_unstemmed Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype
title_short Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype
title_sort quantification of transplant-derived circulating cell-free dna in absence of a donor genotype
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542400/
https://www.ncbi.nlm.nih.gov/pubmed/28771616
http://dx.doi.org/10.1371/journal.pcbi.1005629
work_keys_str_mv AT sharoneilon quantificationoftransplantderivedcirculatingcellfreednainabsenceofadonorgenotype
AT shihao quantificationoftransplantderivedcirculatingcellfreednainabsenceofadonorgenotype
AT kharbandasandhya quantificationoftransplantderivedcirculatingcellfreednainabsenceofadonorgenotype
AT kohwinston quantificationoftransplantderivedcirculatingcellfreednainabsenceofadonorgenotype
AT martinlancer quantificationoftransplantderivedcirculatingcellfreednainabsenceofadonorgenotype
AT khushkirank quantificationoftransplantderivedcirculatingcellfreednainabsenceofadonorgenotype
AT valantinehannah quantificationoftransplantderivedcirculatingcellfreednainabsenceofadonorgenotype
AT pritchardjonathank quantificationoftransplantderivedcirculatingcellfreednainabsenceofadonorgenotype
AT devlaminckiwijn quantificationoftransplantderivedcirculatingcellfreednainabsenceofadonorgenotype